SXTC — China SXT Pharmaceuticals, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1723980 ·
China
Last close
$1.67
Market Cap
$7.44M
52W High
$2.58
52W Low
$1.25
ADV30
21,862
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2025 | — | — | — | — | 26,353,283 | 21,166,494 | 6,119,748 |
| Mar 2025 | — | — | — | — | 21,663,508 | 18,099,019 | 6,223,746 |
| Sep 2024 | — | — | — | — | 29,990,005 | — | 19,808,210 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-34,384,120
Inventory
$751,346
Receivables
$2,865,377
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,537,987
EBITDA
$-8,335,278
Free Cash Flow
$-1,948,357
Enterprise Value
$-18,819,694
Total Cash
$21,306,964
Total Debt
$1,203,223
Shares Out
4,458,077
Trailing EPS
$-57.15
Book Value
$26.16
ROE
-50.3%
ROA
-18.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2025 | 1,740,907 | -2,680,479 | -3,303,652 | 21,663,508 | 6,223,746 | — | -2,345,333 |
| Mar 2024 | 1,928,497 | -2,515,217 | -3,098,532 | 23,127,057 | 9,196,611 | — | -1,928,053 |
| Mar 2023 | 1,971,679 | -5,607,509 | -5,934,772 | 29,554,056 | 14,862,761 | — | -80,757 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CANF | Can-Fite BioPharma Ltd. | $7.37M | $3.44 | — |
| SNGX | SOLIGENIX, INC. | $7.60M | $0.51 | — |
| CNSP | CNS Pharmaceuticals, Inc. | $7.63M | $5.22 | — |
| BETRF | BetterLife Pharma Inc. | $7.67M | $0.05 | — |
| XBIO | Xenetic Biosciences, Inc. | $7.02M | $3.07 | — |
News headlines (Yahoo Finance, 1h cache)
China SXT Pharmaceuticals, Inc. Announces Share Re-classification
2026-03-23 13:00 · Yahoo
BC-Most Active Stocks
2026-02-02 15:30 · Yahoo
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
2026-01-30 14:00 · Yahoo
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
2026-01-15 14:00 · Yahoo
Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)
2026-01-13 22:00 · Yahoo
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
2026-01-09 19:50 · Yahoo
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT
2026-01-08 14:20 · Yahoo
China SXT Pharmaceuticals Full Year 2025 Earnings: US$2.32 loss per share (vs US$28.58 loss in FY 2024)
2025-08-02 13:55 · Yahoo
US Market's Undiscovered Gems Featuring 3 Promising Stocks
2025-07-31 17:33 · Yahoo
Undiscovered Gems in the US Market for July 2025
2025-07-31 11:33 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.